Oppenheimer & Co. Inc. Purchases 4,302 Shares of Addus HomeCare Corporation (NASDAQ:ADUS)

Oppenheimer & Co. Inc. grew its position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 71.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,340 shares of the company's stock after buying an additional 4,302 shares during the period. Oppenheimer & Co. Inc. owned 0.06% of Addus HomeCare worth $1,023,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in ADUS. Capital Research Global Investors bought a new stake in Addus HomeCare in the 4th quarter valued at about $51,149,000. American Century Companies Inc. raised its position in shares of Addus HomeCare by 695.8% in the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock valued at $35,643,000 after purchasing an additional 248,613 shares during the period. GAMMA Investing LLC lifted its stake in shares of Addus HomeCare by 10,307.8% during the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock valued at $12,948,000 after buying an additional 129,672 shares in the last quarter. Bank of America Corp DE lifted its position in shares of Addus HomeCare by 273.6% during the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock worth $21,945,000 after acquiring an additional 128,211 shares in the last quarter. Finally, Pier Capital LLC bought a new position in shares of Addus HomeCare in the fourth quarter worth $8,406,000. Institutional investors own 95.35% of the company's stock.

Insider Activity at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the sale, the executive vice president now owns 7,796 shares in the company, valued at $896,540. The trade was a 20.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 4.60% of the stock is owned by insiders.

Addus HomeCare Trading Down 0.4%

Shares of ADUS opened at $115.12 on Monday. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.74 and a quick ratio of 1.74. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72. The company has a market capitalization of $2.12 billion, a P/E ratio of 25.99, a P/E/G ratio of 1.63 and a beta of 0.81. The firm's 50 day simple moving average is $110.24 and its 200 day simple moving average is $111.59.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The firm had revenue of $337.71 million for the quarter, compared to analysts' expectations of $341.66 million. During the same quarter last year, the company posted $1.21 EPS. The business's quarterly revenue was up 20.3% on a year-over-year basis. Sell-side analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on ADUS shares. Macquarie reiterated an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a research note on Tuesday, June 10th. Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday. JMP Securities restated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a research report on Friday, June 20th. Finally, Stephens reaffirmed an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Seven investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $142.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.